Why is Transgene Biotek falling/rising?

As of 10-Jul, Transgene Biotek Ltd's stock price is currently at 4.99, reflecting an increase of 0.05 or 1.01%. The stock has shown positive momentum, gaining for the last three days with a total return of 3.53% during this period. Additionally, the stock has outperformed its sector by 2.01%. Over the past week, it has risen by 5.50%, and in the last month, it has achieved a significant return of 21.71%. The stock's delivery volume has also increased by 54.67% compared to the five-day average, indicating rising investor participation. However, it is important to note that there is no information available regarding positive or negative factors that could further explain the stock's recent movement.
In the broader market context, Transgene Biotek's short-term performance has been notably stronger than the benchmark Sensex, which has seen a slight decline of 0.06% over the same week. While the stock has been gaining, it is still down 26.94% year-to-date, contrasting with the Sensex's gain of 6.46% during the same period. This divergence suggests that while the stock is currently experiencing a positive trend, it has faced significant challenges over the longer term, as indicated by its 48.45% decline over the past year compared to the benchmark's modest increase.